References

ateroskleroz

Атеросклероз

Ateroscleroz

2078-256X2949-3633

НИИТПМ-филиал ИЦиГ СО РАН

ateroskleroz-744

Research Article

ОБЗОРЫ

REVIEWS

Современные аспекты атеросклероза. Обзор по материалам 83-го конгресса Европейского общества атеросклероза 22–25 марта 2015 г., Глазго, Великобритания

Modern aspects of atherosclerosis. Review of Materials 83rd Congress of the European Atherosclerosis Society 22–25 March 2015, Glasgow, UK

Шахтшнейдер

Е. В.

Shakhtshneider

E. V.

Елена Владимировна Шахтшнейдер, ведущий научный сотрудник

лаборатория молекулярно-генетических исследований терапевтических заболеваний

630089

ул. Бориса Богаткова, 175/1

Новосибирск

630089

Boris Bogatkov str., 175/1

630089

Boris Bogatkov str., 175/1

Novosibirsk

2117409@mail.ru

ФГБНУ «НИИ терапии и профилактической медицины»Research Institute of Internal and Preventive Medicine

2015

17042022

1118186

2022

Шахтшнейдер Е.В.

Shakhtshneider E.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://ateroskleroz.elpub.ru/jour/article/view/744

22–25 марта 2015 г. в Глазго (Великобритания) состоялся 83-й конгресс Европейского общества атеросклероза. Научная программа конгресса была подготовлена с учетом самых современных данных в области изучения проблемы атеросклероза, включая междисциплинарные исследования и новые темы. Ключевыми пунктами программы стали темы: «Новый взгляд на сосудистую стенку», «Инновационные разработки в области регуляции липидного обмена и метаболизма липопротеинов», «Будущие задачи и возможности предотвращения и лечения сердечно-сосудистых заболеваний». В работе конгресса участвовало около 2000 ученых из 77 стран. Тезисы докладов будут опубликованы в журнале «Atherosclerosis». Российские участники представили более 50 постерных докладов, отражающих современные исследования в области атеросклероза. Обзор подготовлен по материалам конгресса EAS 2015 и сайта http://www.eas2015.kenes.com/.

The 83rd European Atherosclerosis Society (EAS) Congress held in Glasgow, UK, March 22-25, 2015. The scientific program of the Congress has been prepared to reflect the most current data of the problem of atherosclerosis. The program included interdisciplinary research and new topics: “A new look at the vascular wall”, “Novel insights into the regulation of lipid and lipoprotein metabolism”, “Future challenges and opportunities in the prevention and treatment of CVD”. This year’s Congress visited above 2000 delegates from 77 countries. Abstracts will be published in the Atherosclerosis journal. Russian participants presented more than 50 poster presentations. The review was prepared based on materials of EAS Congress 2015 and the website http://www.eas2015.kenes.com/.

атеросклерозметаболизм липидовсердечно-сосудистые заболевания

atherosclerosislipid metabolismcardiovascular diseases

References1

Garcia-Garcia H. M., Jang I. K., Serruys P. W., Kovacic J. C., Narula J., Fayad Z. A. Imaging plaques to predict and better manage patients with acute coronary events // Circ. Res. 2014. Vol. 114. P. 1904–1917.

Millon A., Canet-Soulas E., Boussel L., Fayad Z., Douek P. Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression // Vascular. 2014. Vol. 22. P. 221–237.

Giannarelli C., Alique M., Rodriguez D. T., Yang D. K., Jeong D., Calcagno C., Hutter R., Millon A., Kovacic J. C., Weber T., Faries P. L., Soff G. A., Fayad Z. A., Hajjar R. J., Fuster V., Badimon J. J. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of HIF-1α and VEGF signaling // Circulation. 2014 Aug 12. pii: CIRCULA-TIONAHA. 114.006614. [Epub ahead of print].

Warboys C. M., de Luca A., Amini N., Luong L., Duckles H., Hsiao S., White A., Biswas S., Khamis R., Chong C. K., Cheung W. M., Sherwin S. J., Bennett M. R., Gil J., Mason J. C., Haskard D. O., Evans P. C. Disturbed flow promotes endothelial senescence via a p53-dependent pathway // Arterioscler. Thromb. Vasc. Biol. 2014. Vol. 34. P. 985–995.

Gorenne I., Kumar S., Gray K., Figg N., Yu H., Mercer J., Bennett M. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis // Circulation. 2013. Vol. 127. P. 386–396.

Wang J. C., Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence // Circ. Res. 2012. Vol. 111. P. 245–259.

Orlova V. V., Drabsch Y., Freund C., Petrus-Reurer S., van den Hil F. E., Muenthaisong S., Dijke P. T., Mummery C. L. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts // Arterioscler. Thromb. Vasc. Biol. 2014. Vol. 34. P. 177–186.

Birket M. J., Casini S., Kosmidis G., Elliott D. A., Gerencser A. A., Baartscheer A., Schumacher C., Mastroberardino P. G., Elefanty A. G., Stanley E. G., Mummery C. L. PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function // Stem. Cell. Reports. 2013. Vol. 1. P. 560–574.

Mummery C. L., Lee R. T. Is heart regeneration on the right track? // Nat. Med. 2013. Vol. 19. P. 412–413.

Carlo A. S., Nykjaer A., Willnow T. E. Sorting receptor sortilin-a culprit in cardiovascular and neurological diseases // J. Mol. Med. (Berl). 2014. Vol. 92. P. 905–911.

Breiderhoff T., Christiansen G. B., Pallesen L. T., Vaegter C., Nykjaer A., Holm M. M., Glerup S., Willnow T. E. The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-β peptide in the brain // J. Neurosci. 2013. Vol. 33. P. 358–370.

Nykjaer A., Willnow T. E. Sortilin: a receptor to regulate neuronal viability and function // Trends. Neurosci. 2012. Vol. 35. P. 261–270.

Calkin A. C., Lee S. D., Kim J., Van Stijn C. M., Wu X. H., Lusis A. J., Hong C., Tangirala R. I., Tontonoz P. Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice // Circ. Res. 2014. Vol. 115. P. 442–449.

Rong X. L., Albert C. J., Hong C., Duerr M. A., Chamberlain B. T., Tarling E. J., Ito A., Gao J., Wang B., Edwards P. A., Jung M. E., Ford D. A., Tontonoz P. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition // Cell Metab. 2013. Vol. 18. P. 685–697.

Beaven S. W., Matveyenko A., Wroblewski K., Chao L., Wilpitz D., Hsu T. W., Lentz J., Drew B., Hevener A. L., Tontonoz P. Reciprocal regulation of he patic and adipose lipogenesis by liver X receptors in obesity and insulin resistance // Ibid. P. 106–117.

Borén J., Matikainen N., Adiels M., Taskinen M. R. Postprandial hypertriglyceridemia as a coronary risk factor // Clin. Chim. Acta. 2014. Vol. 431. P. 131–142.

Sayin V. I., Khan O. M., Pehlivanoglu L. E., Staffas A., Ibrahim M. X., Asplund A., Agren P., Nilton A., Bergström G., Bergo M. O., Borén J., Lindahl P. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53 // Circ. Res. 2014. Sep 11. [Epub ahead of print].

Akhmedov A., Rozenberg I., Paneni F., Camici G. G., Shi Y., Doerries C., Sledzinska A., Mocharla P., Breitenstein A., Lohmann C., Stein S., von Lukowicz T., Kurrer M. O., Borén J., Becher B., Tanner F. C., Landmesser U., Matter C. M., Lüscher T. F. Endothelial overexpression of LOX-1 increases plaque formation and promotes atheroscleosis in vivo // Eur. Heart J. 2014. Jan. 12. [Epub ahead of print].

Tsimikas S., Duff G. W., Berger P. B., Rogus J., Huttner K., Clopton P., Brilakis E., Kornman K. S., Witztum J. L. Pro-inflammatory interleukin-1 geno types potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phos pholipids and lipoprotein(a) // J. Am. Coll. Cardiol. 2014. Vol. 63. P. 1724–1734.

Willeit P., Kiechl S., Kronenberg F., Witztum J. L., Santer P., Mayr M., Xu Q., Mayr A., Willeit J., Tsimikas S. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): Prospective 15-year outcomes in the Bruneck Study // J. Am. Coll. Cardiol. 2014. Vol. 64. P. 851–860.

Hung M. Y., Witztum J. L., Tsimikas S. New the rapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis // Ibid. 2014. Vol. 63. P. 478–480.

Johnson W., Kuh D., Tikhonoff V., Charakida M., Woodside J., Whincup P., Hughes A. D., Deanfield J. E., Hardy R. NSHD Scientific and Data Collection Teams. Body mass index and height from infancy to adulthood and carotid intima-media thickness at 60 to 64 years in the 1946 British Birth Cohort Study // Arterioscler. Thromb. Vasc. Biol. 2014. Vol. 34. P. 654–660.

JBS3 Board. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) // Heart. 2014. Vol. 100. ii1–ii67.

Charakida M., Jones A., Falaschetti E., Khan T., Finer N., Sattar N., Hingorani A., Lawlor D. A., Smith G. D., Deanfield J. E. Childhood obesity and vascular phenotypes: a population study // J. Am. Coll. Cardiol. 2012. Vol. 60. P. 2643–2650.

Ray K. K., Kastelein J. J., Boekholdt S. M., Nicholls S. J., Khaw K. T., Ballantyne C. M., Catapano A. L., Reiner Ž., Lüscher T. F. The ACC / AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC / EAS guidelines for the management of dyslipidaemias 2011 // Eur. Heart J. 2014. Vol. 35. P. 960–968.

Ray K. K. Interleukin-1 revisited: further insights into its role in atherosclerosis and as a potential therapeutic target for treatment // J. Am. Coll. Cardiol. 2014. Vol. 63. P. 1735–1738.

Ray K. K., Ditmarsch M., Kallend D., Niesor E. J., Suchankova G., Upmanyu R., Anzures-Cabrera J., Lehnert V., Pauly-Evers M., Holme I., Štásek J., van Hessen M. W., Jones P. dal-ACUTE Investigators. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial // Eur. Heart J. 2014. Vol. 35. P. 1792–1800.

Smith J. G., Luk K., Schulz C. A., Engert J. C., Do R., Hindy G., Rukh G., Dufresne L., Almgren P., Owens D. S., Harris T. B., Peloso G. M., Kerr K. F., Wong Q., Smith A. V., Budoff M. J., Rotter J. I., Cupples L. A., Rich S., Kathiresan S., Orho-Melander M., Gudnason V., O’Donnell C. J., Post W. S., Thanassoulis G. For the Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) Extracoronary Calcium Working Group. Association of Low-Density Lipoprotein Cholesterol-Related Genetic variants with aortic valve calcium and incident aortic stenosis // JAMA. 2014. [Epub ahead of print].

Tada H., Won H. H., Melander O., Yang J., Peloso G. M., Kathiresan S. Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease // Circ. Cardiovasc. Genet. 2014. [Epub ahead of print].

TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Cros by J., Peloso G. M., Auer P. L., Crosslin D. R., Stitziel N. O., Lange L. A., Lu Y., Tang Z. Z., Zhang H., Hindy G., Masca N., Stirrups K., Kanoni S., Do R., Jun G., Hu Y., Kang H. M., Xue C., Goel A., Farrall M., Duga S., Merlini P. A., Asselta R., Girelli D., Olivieri O., Martinelli N., Yin W., Reilly D., Speliotes E., Fox C. S., Hveem K., Holmen O. L., Nikpay M., Farlow D. N., Assimes T. L., Franceschini N., Robinson J., North K. E., Martin L. W., De Pristo M., Gupta N., Escher S. A., Jansson J. H., Van Zuydam N., Palmer C. N., Wareham N., Koch W., Meitinger T., Peters A., Lieb W., Erbel R., Konig I. R., Kruppa J., Degenhardt F., Gottesman O., Bottinger E. P., O’Donnell C. J., Psaty B. M., Ballantyne C. M., Abecasis G., Ordovas J. M., Melander O., Watkins H., Orho-Melan der M., Ardissino D., Loos R. J., McPherson R, Willer C. J., Erdmann J., Hall A. S., Samani N. J., Deloukas P., Schunkert H., Wilson J. G., Kooperberg C., Rich S. S., Tracy R. P., Lin D. Y., Altshuler D., Gabriel S., Nickerson D. A., Jarvik G. P., Cupples L. A., Reiner A. P., Boerwinkle E., Kathiresan S. Loss-of-function mutations in APOC3, triglycerides, and coronary disease // N. Engl. J. Med. 2014. Vol. 371. P. 22–31.

Reiner Z., Catapano A. L., De Backer G., Graham I., Taskinen M. R., Wiklund O., Agewall S., Alegria E., Chapman M. J., Durrington P., Erdine S., Halcox J., Hobbs R., Kjekshus J., Filardi P. P., Riccardi G., Storey R. F. 1. Wood D. ESC / EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) // Eur. Heart J. 2011. Vol. 32. P. 1769–1818.

Estruch R., Ros E., Salas-Salvadó J., Covas M. I., Corella D., Arуs F., Gómez-Gracia E., Ruiz-Gutiérrez V., Fiol M., Lapetra J., Lamuela-Raventos R. M., Serra-Majem L., Pintó X., Basora J., Muñoz M. A., Sorlí J. V., Martínez J. A., Martínez-González M. A. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet // N. Engl. J. Med. 2013. Vol. 368. P. 1279–1290.

Ramprasath V. R., Jenkins D. J., Lamarche B., Kendall C. W., Faulkner D., Cermakova L., Couture P., Ireland C., Abdulnour S., Patel D., Bashyam B., Srichaikul K., de S. R., Vidgen E., Josse R. G., Leiter L. A., Connelly P. W., Frohlich J., Jones P. J. Consumption of a dietary portfolio of cholesterol lowering foods improves blood lipids without affecting concentrations of fat soluble compounds // Nutr. J. 2014. Vol. 13. P.101.

The authors declare that there are no conflicts of interest present.